trial
support
superior
convent
vasopressor
patient
vasodilatori
shock
physiolog
rational
use
drug
strong
graviti
current
situat
mandat
altern
therapi
consid
e
angiotensin
angiotensin
ii
apach
acut
physiolog
chronic
health
evalu
ard
acut
respiratori
distress
syndrom
angiotensin
type
angiotensin
type
angiotensin
ii
treatment
high
output
shock
ci
confid
interv
coronaviru
diseas
ecmo
extracorpor
membran
oxygen
edhf
endotheliumderiv
hyperpolar
factor
icu
intens
care
unit
ma
mitochondri
assembl
protein
nitric
oxid
raa
reninangiotensinaldosteron
system
rrt
renal
replac
therapi
sar
sever
acut
respiratori
syndrom
c
oronaviru
diseas
first
appear
wuhan
china
earli
decemb
sinc
world
health
organ
classifi
pandem
april
countri
report
million
confirm
case
death
cohort
patient
sever
diseas
hospit
die
subgroup
patient
admit
intens
care
unit
icu
requir
mechan
ventil
die
diseas
requir
continu
renal
replac
therapi
rrt
develop
septic
shock
develop
acut
respiratori
distress
syndrom
ard
given
high
morbid
mortal
cohort
must
util
medic
alreadi
avail
today
alter
pathophysiolog
clinic
cours
diseas
may
improv
outcom
await
develop
target
antivir
therapi
vaccin
ard
increas
alveolarcapillari
barrier
permeabl
reduc
surfact
product
amplifi
cytokin
interleukin
product
increas
risk
septic
shock
culmin
sever
pulmonari
endotheli
damag
angiotensinconvert
enzym
ace
also
locat
pulmonari
endothelium
proinflammatori
process
sever
disrupt
ace
function
ace
integr
reninangiotensinaldosteron
system
raa
one
physiolog
pathway
function
concert
argininevasopressin
sympathet
nervou
system
autoregul
hemodynam
human
dysfunct
ace
hazard
ratio
confid
interv
ci
p
raa
estim
fix
effect
renin
ci
p
associ
decreas
surviv
septic
shock
without
function
ace
ard
angiotensin
hydrolyz
angiotensin
ii
contribut
hypotens
via
distinct
mechan
first
inadequ
product
directli
lead
decreas
angiotensin
type
receptor
agon
figur
lead
decreas
vascular
smooth
muscl
constrict
decreas
free
water
sodium
reabsorpt
kidney
decreas
aldosteron
cortisol
vasopressin
releas
hypothalamicpituitaryadren
axi
second
lead
excess
accumul
metabol
angiotensin
ang
angiotensin
ang
agon
vasodilatori
mitochondri
assembl
protein
ma
angiotensin
type
receptor
figur
third
ang
directli
activ
nitric
oxid
synthas
stimul
product
anoth
potent
vasodil
fourth
impair
acedepend
hydrolysi
bradykinin
bradykinin
bradykinin
lead
excess
accumul
bradykinin
figur
vasodilatori
substanc
agon
b
receptor
caus
releas
prostacyclin
endotheliumderiv
hyperpolar
factor
edhf
chang
strong
physiolog
rational
exist
util
exogen
treat
vasodilatori
shock
exogen
target
raa
replac
deplet
endogen
store
agon
receptor
increas
vascular
tone
furthermor
increas
renal
perfus
decreas
renin
secret
exogen
decreas
product
mitig
secondari
ma
b
bradykinininduc
vasodilat
angiotensin
ii
treatment
high
output
shock
trial
found
effect
increas
mean
arteri
pressur
decreas
background
norepinephrin
dose
one
studi
found
patient
vasodilatori
shock
rapidli
respond
exogen
defin
abil
downtitr
dose
ngkgmin
within
minut
initi
significantli
lower
level
baselin
endogen
mean
pgml
rapid
respond
versu
pgml
nonrapid
respond
p
subsequ
decreas
mortal
rapid
respond
versu
nonrapid
respond
p
rapidli
respond
addit
associ
decreas
mortal
patient
acut
physiolog
chronic
health
evalu
apach
ii
score
mortal
versu
convent
vasopressor
p
patient
acut
kidney
injuri
aki
rrt
mortal
versu
convent
vasopressor
p
furthermor
patient
experienc
increas
rate
liber
rrt
day
versu
convent
vasopressor
p
compar
receiv
convent
vasopressor
critic
ill
patient
requir
rrt
continu
exponenti
increas
number
case
worldwid
larg
number
patient
might
benefit
earlier
util
although
physiolog
effect
raa
known
mani
question
remain
current
evid
suggest
sever
acut
respiratori
syndrom
sar
viru
caus
bind
angiotensinconvert
enzym
receptor
time
affin
sarscov
identifi
requir
cell
entri
viral
replic
exogen
shown
downregul
intern
degrad
anim
model
vitro
studi
human
cell
unknown
whether
downregulatori
effect
modul
rate
cell
entri
viral
replic
viral
load
enzym
activ
measur
patient
receiv
vasopressor
better
character
effect
patient
disrupt
ace
function
ard
sepsi
make
earli
exogen
administr
physiolog
ration
choic
treatment
vasodilatori
shock
anticip
widespread
shortag
lifesustain
equip
ventil
continu
rrt
machin
extracorpor
membran
oxygen
ecmo
circuit
critic
care
personnel
rrttrain
nurs
intensivist
respiratori
therapist
hospit
resourc
critic
care
bed
emerg
depart
bed
person
protect
equip
everi
singl
rrtfree
hypotensionfre
ventilatorfre
icufre
day
matter
although
current
figur
normal
function
ace
ace
hydrolyz
act
receptor
caus
vasoconstrict
ace
also
requir
point
hydrolysi
bradykinin
bradykinin
bradykinin
ace
indic
angiotensinconvert
enzym
angiotensin
angiotensin
ii
angiotensin
type
figur
effect
ace
dysfunct
metabolit
accumul
dysfunct
ace
result
endotheli
damag
ard
septic
shock
prevent
hydrolysi
occur
accumul
excess
metabol
ang
ang
ang
lead
activ
nitric
oxid
synthas
agon
b
ma
receptor
lead
vasodilat
addit
ace
dysfunct
prevent
degrad
bradykinin
bradykinin
bradykinin
result
excess
accumul
bradykinin
potent
vasodilat
figur
creat
motifolio
toolkit
motifolio
inc
ellicott
citi
md
ace
indic
angiotensinconvert
enzym
ang
angiotensin
ang
angiotensin
angiotensin
angiotensin
ii
ard
acut
respiratori
distress
syndrom
angiotensin
type
ma
mitochondri
assembl
protein
raa
reninangiotensinaldosteron
system
